Scoliosis Treatment Market Research Report - Global Forecast till 2027

Global Scoliosis Treatment Market Research Report: Information by Disease (Infantile Idiopathic Scoliosis and Adolescent Idiopathic Scoliosis), Product (Cervical Thoracic Lumbar Sacral Orthosis (CTLSO), Thoracolumbosacral Orthosis (TLSO) and Lumbosacral Orthosis (LSO)), Distribution Channel (Hospitals & Clinics, Retail Pharmacies and Online Pharmacies) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/6758-HCR | February 2021 | Region: Global | 95 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario


The Global Scoliosis Treatment Market is expected to register a CAGR of ~ 3.9% during the forecast period of 2019 to 2025 with a market value of USD 2,580.2 million in 2018.


Scoliosis is an abnormal curve in the spinal cord. Depending on the severity of the curve and the risk of it deteriorating, scoliosis can be treated with bracing or surgery. There is no cure for scoliosis, but the pain can be alleviated. The global scoliosis treatment market is driven by factors such as the increasing prevalence of scoliosis and the high adoption rate of braces to reduce the severe pain. Additionally, the growing demand for spine surgeries coupled with the growing incidence of musculoskeletal disorders are anticipated to fuel the market growth. For instance, as per the National Scoliosis Foundation (NSF), around 2% to 3% of the general population, approximately 7 million people, encounter scoliosis in the US. On the other hand, the high cost of treatment or procedures is projected to hamper the growth of the market during the assessment period. Moreover, major companies in the market are involved in strategic product approvals, acquisitions, collaborations, and mergers to sustain their position in the market.


For instance, in August 2019, Zimmer Biomet Holdings Inc. announced it had received FDA approval of ‘Tether,’ the first spinal device intended for children and adolescents to correct idiopathic scoliosis that has not responded to conservative treatment


Segmentation


The global scoliosis treatment market has been segmented based on disease, product, distribution channel, and region. The market, based on disease, has been bifurcated into infantile idiopathic scoliosis and adolescent idiopathic scoliosis. The product segment has been further divided into cervical, thoracic, lumbar-sacral orthosis (CTLSO), thoracolumbosacral orthosis (TLSO), and lumbosacral orthosis (LSO). The distribution channel segment has been segregated into hospitals & clinics, retail pharmacies, and online pharmacies. The market has been classified, by region, like the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The scoliosis treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European scoliosis treatment market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The scoliosis treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The scoliosis treatment market in the Middle East & Africa has been categorized as the Middle East and Africa.


Key Players



  • Boston Orthotics & Prosthetics

  • Chaneco

  • Charleston Bending Brace

  • Orthotech

  • Trulife

  • Össur

  • DJO

  • SPINEFORM LLC

  • Wilmington Orthotics & Prosthetics, Inc.

  • Lawall Prosthetics and Orthotics

  • Horton's Orthotics & Prosthetics

  • Aspen Medical Products

  • UNYQ

  • C H Martin Company

  • Optec USA, Inc.

  • Spinal Technology, Inc.

  • Zimmer Biomet Holdings Inc.

  • NuVasive


Regional Market Summary


Global scoliosis Treatment Market Share by Region, 2018 (%)
 scoliosis Treatment Market


Source: World Health Organization (WHO)


The market in the Americas is expected to dominate the global scoliosis treatment market due to the increasing per capita healthcare expenditure and the high adoption of new technology in the region. High cases of scoliosis in the US and Canada is expected to drive the market growth.


Furthermore, increasing expenses in research by healthcare bodies is expected to fuel the growth of the market in this region. The market in Europe showed a considerable amount of growth. This can be attributed to the presence of a well-established healthcare system, the advancement of technology, and the involvement of critical companies. For instance, in January 2016, NuVasive Inc., acquired Ellipse Technologies the acquisition of Ellipse will aggressively insert NuVasive into early-onset and idiopathic scoliosis, an important and attractive part of the spinal deformity market for NuVasive where it has tremendous opportunities for accelerated growth in the scoliosis treatment market. Therefore, the market is expected to grow during the forecast period. The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to the increasing demand for spine surgeries and increasing government initiatives for healthcare reforms. The market in the Middle East & Africa is projected to account for the least share of the global market due to low disposable income in the region.


Global scoliosis Treatment Market, by Disease



  • Infantile Idiopathic Scoliosis

  • Adolescent Idiopathic Scoliosis


Global Scoliosis Treatment Market, by Product



  • Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)

  • Thoracolumbosacral Orthosis (TLSO)

  • Lumbosacral Orthosis (LSO)


Global Scoliosis Treatment Market, by Distribution channel



  • Hospitals & Clinics

  • Retail Pharmacies

  • Online Pharmacies


Global Scoliosis Treatment Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Medical device companies

  • Government research institutes

  • Academic institutes and universities

  • Venture capitalists



Frequently Asked Questions (FAQ) :


The scoliosis treatment market is projected to grow at a 3.9% CAGR between 2019-2025.

The Americas are predicted to have the largest share in the scoliosis treatment market.

Rising prevalence of scoliosis & musculoskeletal disorders and growing demand for spine injuries are boosting market growth.

Lack of awareness and high cost may restrict market growth.

Hospitals and clinics will dominate the scoliosis treatment market?

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Product Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Scoliosis Treatment Market, by Disease

6.1 Introduction

6.2 Infantile Idiopathic Scoliosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Adolescent Idiopathic Scoliosis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Scoliosis Treatment Market, by Product

8.1 Introduction

8.2 Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Thoracolumbosacral Orthosis (TLSO)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Lumbosacral Orthosis (LSO)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Scoliosis Treatment Market, by Distribution channel

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Retail Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Online Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Market Estimates & Forecast, by Country, 2020-2027

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Boston Orthotics & Prosthetics

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Chaneco

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Charleston Bending Brace

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Orthotech

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Trulife

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Össur

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 DJO

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 SPINEFORM LLC

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Wilmington Orthotics & Prosthetics, Inc.

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Lawall Prosthetics and Orthotics

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Horton's Orthotics & Prosthetics

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Aspen Medical Products

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 UNYQ

12.13.1 Overview

12.13.2 Product Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

12.14 C H Martin Company

12.14.1 Overview

12.14.2 Product Overview

12.14.3 Financials

12.14.4 Key Developments

12.14.5 SWOT Analysis

12.15 Optec USA, Inc.

12.15.1 Overview

12.15.2 Product Overview

12.15.3 Financials

12.15.4 Key Developments

12.15.5 SWOT Analysis

12.16 Spinal Technology, Inc.

12.16.1 Overview

12.16.2 Product Overview

12.16.3 Financials

12.16.4 Key Developments

12.16.5 SWOT Analysis

12.17 Zimmer Biomet Holdings Inc.

12.17.1 Overview

12.17.2 Product Overview

12.17.3 Financials

12.17.4 Key Developments

12.17.5 SWOT Analysis

12.18 NuVasive

12.18.1 Overview

12.18.2 Product Overview

12.18.3 Financials

12.18.4 Key Developments

12.18.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Cell Surface Markers Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Scoliosis Treatment Market Synopsis, 2020-2027

Table 2 Global Scoliosis Treatment Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Scoliosis Treatment Market, by Region, 2020-2027 (USD Million)

Table 4 Global Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 5 Global Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 6 Global Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 7 North America: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 8 North America: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 9 North America: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 10 Latin America: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 11 Latin America: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 12 Latin America: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 13 Europe: Scoliosis Treatment Market, by Disease tye, 2020-2027 (USD Million)

Table 14 Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 15 Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 16 Western Europe: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 17 Western Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 18 Western Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 19 Eastern Europe: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 20 Eastern Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 21 Eastern Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 22 Asia-Pacific: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 23 Asia-Pacific: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

Table 24 Asia-Pacific: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

Table 25 Middle East & Africa: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

Table 26 Middle East & Africa: Scoliosis Treatment Market, by Product, 2020-2027

(USD Million)

Table 27 Middle East & Africa: Scoliosis Treatment Market, by Distribution channel, 2020-2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Scoliosis Treatment Market

Figure 3 Market Dynamics for Global Scoliosis Treatment Market

Figure 4 Global Scoliosis Treatment, by Disease, 2020

Figure 5 Global Scoliosis Treatment Market Share, by Product, 2020

Figure 6 Global Scoliosis Treatment Market Share, by Distribution channel, 2020

Figure 7 Global Scoliosis Treatment Market Share, by Region, 2020

Figure 8 North America: Scoliosis Treatment Market Share, by Country, 2020

Figure 9 Europe: Scoliosis Treatment Market Share, by Country, 2020

Figure 10 Asia-Pacific: Scoliosis Treatment Market Share, by Country, 2020

Figure 11 Middle East & Africa: Scoliosis Treatment Market Share, by Country, 2020

Figure 12 Global Scoliosis Treatment Market: Company Share Analysis, 2020 (%)

Figure 13 Boston Orthotics & Prosthetics, Inc.: Key Financials

Figure 14 Boston Orthotics & Prosthetics, Inc.: Segmental Revenue

Figure 15 Boston Orthotics & Prosthetics, Inc.: Geographical Revenue

Figure 16 Chaneco Medical Solutions: Key Financials

Figure 17 Chaneco Medical Solutions: Segmental Revenue

Figure 18 Chaneco Medical Solutions: Geographical Revenue

Figure 19 Charleston Bending Brace: Key Financials

Figure 20 Charleston Bending Brace: Segmental Revenue

Figure 21 Charleston Bending Brace: Geographical Revenue

Figure 22 Orthotech: Key Financials

Figure 23 Orthotech: Segmental Revenue

Figure 24 Orthotech: Geographical Revenue

Figure 25 Trulife: Key Financials

Figure 26 Trulife: Segmental Revenue

Figure 27 Trulife: Geographical Revenue

Figure 28 Össur: Key Financials

Figure 29 Össur: Segmental Revenue

Figure 30 Össur: Geographical Revenue

Figure 31 DJO: Key Financials

Figure 32 DJO: Segmental Revenue

Figure 33 DJO: Geographical Revenue

Figure 34 SPINEFORM LLC: Financials

Figure 35 SPINEFORM LLC: Segmental Revenue

Figure 36 SPINEFORM LLC: Geographical Revenue

Figure 37 Wilmington Orthotics & Prosthetics, Inc.: Key Financials

Figure 38 Wilmington Orthotics & Prosthetics, Inc.: Segmental Revenue

Figure 39 Wilmington Orthotics & Prosthetics, Inc.: Geographical Revenue

Figure 40 Lawall Prosthetics and Orthotics: Key Financials

Figure 41 Lawall Prosthetics and Orthotics: Segmental Revenue

Figure 42 Lawall Prosthetics and Orthotics: Geographical Revenue

Figure 43 Horton's Orthotics & Prosthetics: Key Financials

Figure 44 Horton's Orthotics & Prosthetics: Segmental Revenue

Figure 45 Horton's Orthotics & Prosthetics: Geographical Revenue

Figure 46 Aspen Medical Products: Key Financials

Figure 47 Aspen Medical Products: Segmental Revenue

Figure 48 Aspen Medical Products: Geographical Revenue

Figure 49 UNYQ: Key Financials

Figure 50 UNYQ: Segmental Revenue

Figure 51 UNYQ: Geographical Revenue

Figure 52 C H Martin Company: Key Financials

Figure 53 C H Martin Company: Segmental Revenue

Figure 54 C H Martin Company: Geographical Revenue

Figure 55 Optec USA, Inc.: Key Financials

Figure 56 Optec USA, Inc.: Segmental Revenue

Figure 57 Optec USA, Inc.: Geographical Revenue

Figure 58 Spinal Technology, Inc.: Key Financials

Figure 59 Spinal Technology, Inc.: Segmental Revenue

Figure 60 Spinal Technology, Inc.: Geographical Revenue

Figure 61 Zimmer Biomet Holdings Inc.: Key Financials

Figure 62 Zimmer Biomet Holdings Inc.: Segmental Revenue

Figure 63 Zimmer Biomet Holdings Inc.: Geographical Revenue

Figure 64 NuVasive: Key Financials

Figure 65 NuVasive: Segmental Revenue

Figure 66 NuVasive: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.